275 related articles for article (PubMed ID: 36466349)
1. The application of nanotechnology in treatment of Alzheimer's disease.
Cao Y; Zhang R
Front Bioeng Biotechnol; 2022; 10():1042986. PubMed ID: 36466349
[TBL] [Abstract][Full Text] [Related]
2. Nanotechnology in the diagnostic and therapy for Alzheimer's disease.
Panghal A; Flora SJS
Biochim Biophys Acta Gen Subj; 2024 Mar; 1868(3):130559. PubMed ID: 38191034
[TBL] [Abstract][Full Text] [Related]
3. The Potential Benefits of Nanotechnology in Treating Alzheimer's Disease.
Ling TS; Chandrasegaran S; Xuan LZ; Suan TL; Elaine E; Nathan DV; Chai YH; Gunasekaran B; Salvamani S
Biomed Res Int; 2021; 2021():5550938. PubMed ID: 34285915
[TBL] [Abstract][Full Text] [Related]
4. Advancements in the Application of Nanomedicine in Alzheimer's Disease: A Therapeutic Perspective.
Puranik N; Yadav D; Song M
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762346
[TBL] [Abstract][Full Text] [Related]
5. Nanomedicines in the Management of Alzheimer's Disease: Current View and Future Prospects.
Chopra H; Bibi S; Singh I; Kamal MA; Islam F; Alhumaydhi FA; Emran TB; Cavalu S
Front Aging Neurosci; 2022; 14():879114. PubMed ID: 35875806
[TBL] [Abstract][Full Text] [Related]
6. Development of nanomedicines for the treatment of Alzheimer's disease: Raison d'être, strategies, challenges and regulatory aspects.
Mazahir F; Alam MI; Yadav AK
Ageing Res Rev; 2024 Jul; 98():102318. PubMed ID: 38705362
[TBL] [Abstract][Full Text] [Related]
7. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
Elife; 2020 Mar; 9():. PubMed ID: 32228858
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine as a promising approach for the treatment and diagnosis of brain diseases: the example of Alzheimer's disease.
Andrieux K; Couvreur P
Ann Pharm Fr; 2013 Jul; 71(4):225-33. PubMed ID: 23835020
[TBL] [Abstract][Full Text] [Related]
9. Neurotherapeutic applications of nanomedicine for treating Alzheimer's disease.
Wilson B; Geetha KM
J Control Release; 2020 Sep; 325():25-37. PubMed ID: 32473177
[TBL] [Abstract][Full Text] [Related]
10. Emerging nanotechnology for Alzheimer's disease: From detection to treatment.
Song N; Sun S; Chen K; Wang Y; Wang H; Meng J; Guo M; Zhang XD; Zhang R
J Control Release; 2023 Aug; 360():392-417. PubMed ID: 37414222
[TBL] [Abstract][Full Text] [Related]
11. Advancements in nanotherapeutics for Alzheimer's disease: current perspectives.
Harilal S; Jose J; Parambi DGT; Kumar R; Mathew GE; Uddin MS; Kim H; Mathew B
J Pharm Pharmacol; 2019 Sep; 71(9):1370-1383. PubMed ID: 31304982
[TBL] [Abstract][Full Text] [Related]
12. Nanomedicine Strategies for Sustained, Controlled and Targeted Treatment of Alzheimer's Disease.
Ma TJ; Gao J; Liu Y; Zhuang JH; Yin C; Li P; Mao L; Xu J; Xu YX; Li YP; Zhao ZX; Yin Y
Mini Rev Med Chem; 2018; 18(12):1035-1046. PubMed ID: 29243575
[TBL] [Abstract][Full Text] [Related]
13. Flavonoid-Based Nanomedicines in Alzheimer's Disease Therapeutics: Promises Made, a Long Way To Go.
Prasanna P; Upadhyay A
ACS Pharmacol Transl Sci; 2021 Feb; 4(1):74-95. PubMed ID: 33615162
[TBL] [Abstract][Full Text] [Related]
14. Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease.
Li L; Zhang J; Huang X; Du J; Tu Z; Wu H; Liu X; Yuan M
Curr Pharm Des; 2023; 29(2):95-115. PubMed ID: 36529920
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease: review of current nanotechnological therapeutic strategies.
Baranowska-Wójcik E; Szwajgier D
Expert Rev Neurother; 2020 Mar; 20(3):271-279. PubMed ID: 31957510
[No Abstract] [Full Text] [Related]
16. Advances on Therapeutic Strategies for Alzheimer's Disease: From Medicinal Plant to Nanotechnology.
Hassan NA; Alshamari AK; Hassan AA; Elharrif MG; Alhajri AM; Sattam M; Khattab RR
Molecules; 2022 Jul; 27(15):. PubMed ID: 35956796
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic nanotechnologies for Alzheimer's disease: A critical analysis of recent trends and findings.
Delbreil P; Rabanel JM; Banquy X; Brambilla D
Adv Drug Deliv Rev; 2022 Aug; 187():114397. PubMed ID: 35738546
[TBL] [Abstract][Full Text] [Related]
18. Nanomedicine-based immunotherapy for Alzheimer's disease.
Hoque M; Samanta A; Alam SSM; Zughaibi TA; Kamal MA; Tabrez S
Neurosci Biobehav Rev; 2023 Jan; 144():104973. PubMed ID: 36435391
[TBL] [Abstract][Full Text] [Related]
19. Immunosenescence and Aging: Neuroinflammation Is a Prominent Feature of Alzheimer's Disease and Is a Likely Contributor to Neurodegenerative Disease Pathogenesis.
Bowirrat A
J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36579548
[TBL] [Abstract][Full Text] [Related]
20. The Structure and Function of α, β and γ-Secretase as Therapeutic Target Enzymes in the Development of Alzheimer's Disease: A Review.
Ahmad SS; Khan S; Kamal MA; Wasi U
CNS Neurol Disord Drug Targets; 2019; 18(9):657-667. PubMed ID: 31608840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
